U.S. Physical Therapy, Inc. (USPH) Issues Earnings Results, Misses Expectations By $0.04 EPS
U.S. Physical Therapy, Inc. (NYSE:USPH) posted its quarterly earnings data on Thursday. The company reported $0.48 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.52 by ($0.04), Bloomberg Earnings reports. The company had revenue of $103.03 million for the quarter, compared to analyst estimates of $102.69 million. U.S. Physical Therapy had a return on equity of 10.27% and a net margin of 6.13%.
Shares of U.S. Physical Therapy (NYSE:USPH) traded down $1.75 during midday trading on Friday, hitting $66.30. 105,690 shares of the stock were exchanged, compared to its average volume of 66,321. The firm has a market cap of $906.48, a price-to-earnings ratio of 34.81 and a beta of 1.07.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 8th. Shareholders of record on Friday, November 17th will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 1.21%. The ex-dividend date is Thursday, November 16th. U.S. Physical Therapy’s dividend payout ratio is presently 48.19%.
In other news, COO Glenn Mcdowell sold 1,004 shares of the stock in a transaction dated Tuesday, August 29th. The shares were sold at an average price of $57.01, for a total value of $57,238.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Bernard A. Harris, Jr. sold 5,000 shares of the stock in a transaction dated Thursday, August 10th. The shares were sold at an average price of $62.00, for a total transaction of $310,000.00. Following the completion of the sale, the director now owns 26,422 shares of the company’s stock, valued at $1,638,164. The disclosure for this sale can be found here. Insiders sold 13,266 shares of company stock valued at $801,134 over the last quarter. Company insiders own 3.10% of the company’s stock.
USPH has been the subject of a number of research analyst reports. BidaskClub cut shares of U.S. Physical Therapy from a “sell” rating to a “strong sell” rating in a research report on Sunday, July 16th. Cantor Fitzgerald initiated coverage on shares of U.S. Physical Therapy in a research report on Monday, July 24th. They set an “overweight” rating and a $72.00 price objective for the company. Zacks Investment Research upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $64.00 price objective for the company in a research report on Tuesday, August 29th. Sidoti upgraded shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $62.00 to $74.00 in a research report on Friday, September 8th. Finally, Jefferies Group LLC set a $65.00 price objective on shares of U.S. Physical Therapy and gave the stock a “hold” rating in a research report on Friday, August 4th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the stock. U.S. Physical Therapy currently has a consensus rating of “Hold” and a consensus price target of $69.00.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.